Comparative Effects of Virtual Reality and Frenkel's Exercises in Patients With Stroke.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 15, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two different rehabilitation methods for patients who have had a stroke: Virtual Reality (VR) exercises and Frenkel's exercises. The goal is to find out which method better helps improve balance, walking, and overall quality of life for stroke survivors. If you or a loved one is between the ages of 40 and 65 and has experienced a stroke, you might be eligible to participate in this study, especially if the stroke occurred recently and you haven't used VR rehabilitation before.
Participants in this trial can expect to engage in either VR exercises or traditional exercises designed to improve their physical abilities. The study is currently recruiting participants and aims to include individuals who have a good level of mental clarity, as measured by a simple test. However, those with serious mental health issues, recent injuries, or other specific health concerns may not qualify. This trial provides an opportunity to explore innovative rehabilitation options that could lead to better recovery outcomes for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1- Age 40-65 years. 2. Stroke patients with both genders. 3. Subacute stroke patients will be included. 4. Survivors of ischemic stroke. 5. No prior experience with VR-based rehabilitation. 6. Patients with ≥24 Mini-Mental State Exam score.
- Exclusion Criteria:
- • 1. Patient with serious behavioral problems or mental health.
- • 2. Patients with recent lower extremity deep vein thrombosis, quadriplegia, Parkinson's disease, lower limb fractures, or recent myocardial infarction.
- • 3. Patients with malignant tumor, or other unstable condition.
- • 4. Participants with ENT defect, hearing, majorly affected vision(blindness), cataract, glaucoma, loss of vision.
- • 5. Subjects with diagnosed vestibular disease.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Alveena Fatima, Ms.NMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported